DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Jayant Agro Organics Limited — Outcome of Board Meeting

NSE 4 hrs ago·31 Jul 2026, 3:30 pm

Jayant Agro Organics

Jayant Agro Organics Limited has informed the stock exchanges that its board has approved the financial results for the period ending June 30, 2026. The company has submitted these documents to comply with regulatory disclosure norms. This update confirms that the company's financial performance for the quarter is now officially on record with the market regulator.

For investors, this disclosure is a routine but necessary step in the corporate reporting cycle. It provides the market with the official data required to assess the company's current financial health and operational status. Investors should review the detailed results to understand the company's performance against market expectations.

Moving forward, market participants will focus on the specific figures within the results, including revenue growth and profit margins. The stock's reaction will likely depend on how these numbers compare to analyst forecasts and the company's previous quarterly performance.